Trial Profile
Cardiovascular Events in Hypertensive Hemodialysed Patients: Aliskiren Versus Amlodipine. A Randomized, Double-blind Study.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2017
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Amlodipine
- Indications Cardiovascular disorders; Hypertension
- Focus Therapeutic Use
- Acronyms AL-AM dial
- 09 Jul 2012 Planned End Date changed from 1 Jan 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 16 Jul 2011 New trial record